These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7435364)

  • 21. Enterprising pharmacists use Medicare card to lower costs for health system, patients.
    Young D
    Am J Health Syst Pharm; 2004 Dec; 61(23):2462, 2465-6, 2472. PubMed ID: 15595218
    [No Abstract]   [Full Text] [Related]  

  • 22. Differential pricing of pharmaceuticals and retail competition under the Robinson-Patman Act.
    Abood RR
    Am J Law Med; 1985; 11(3):293-317. PubMed ID: 3842232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The practice of pharmacists.
    Tatro DS
    N Engl J Med; 1969 Sep; 281(13):741. PubMed ID: 5821173
    [No Abstract]   [Full Text] [Related]  

  • 24. Judicial views of the pharmacist's professional status.
    Fink JL
    Drug Intell Clin Pharm; 1979 Jan; 13(1):30-6. PubMed ID: 10240008
    [No Abstract]   [Full Text] [Related]  

  • 25. Responsive regulation of Internet pharmacy practice.
    Brushwood DB
    Ann Health Law; 2001; 10():75-103. PubMed ID: 11496591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical costs. An overview and analysis of legal and policy responses by the states.
    Latham SR
    J Leg Med; 2003 Jun; 24(2):141-73. PubMed ID: 12775406
    [No Abstract]   [Full Text] [Related]  

  • 27. Hospital retail pharmacies: new limits.
    Robinson ML
    Hospitals; 1987 Sep; 61(18):26. PubMed ID: 3305297
    [No Abstract]   [Full Text] [Related]  

  • 28. Standards of practice for the profession of pharmacy.
    Kalman SH; Schlegel JF
    Am Pharm; 1979 Mar; 19(3):21-33. PubMed ID: 420093
    [No Abstract]   [Full Text] [Related]  

  • 29. Financial impact of a pharmacist-managed medication refill clinic.
    Nelson LA; Downs GE; Cummings DM; Seaman JJ
    Mil Med; 1984 May; 149(5):254-6. PubMed ID: 6427688
    [No Abstract]   [Full Text] [Related]  

  • 30. Economic consequences of the maximum allowable cost program to the entire profession of pharmacy.
    Paul SH
    Med Mark Media; 1979 Aug; 14(8):19-26. PubMed ID: 10243270
    [No Abstract]   [Full Text] [Related]  

  • 31. [Information in pharmacy. 2. Information need in pharmacy].
    Schubert M; Rogowski K
    Pharm Prax; 1972; 4():Suppl 4:73-83. PubMed ID: 5053044
    [No Abstract]   [Full Text] [Related]  

  • 32. Analyzing contrasting approaches to drug services.
    Johnson RE; Campbell WH
    Med Care; 1974 Jan; 12(1):62-74. PubMed ID: 4811403
    [No Abstract]   [Full Text] [Related]  

  • 33. Creating pharmacy's future.
    Schwartz MA
    Am Pharm; 1994 Oct; NS34(10):44-5, 59. PubMed ID: 7992791
    [No Abstract]   [Full Text] [Related]  

  • 34. Do you believe in magic? improving the quality of pharmacy services through restricting entry and aspirational contracts, the Irish experience.
    Gorecki PK
    Eur J Health Econ; 2011 Dec; 12(6):521-31. PubMed ID: 20617359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of online pharmacies: a case for cooperative federalism.
    Zeman SE
    Spec Law Dig Health Care Law; 2002 Jul; (279):9-41. PubMed ID: 12221740
    [No Abstract]   [Full Text] [Related]  

  • 36. Does deregulation in community pharmacy impact accessibility of medicines, quality of pharmacy services and costs? Evidence from nine European countries.
    Vogler S; Habimana K; Arts D
    Health Policy; 2014 Sep; 117(3):311-27. PubMed ID: 24962537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescription or proscription? The general failure of attempts to litigate and legislate against PBMS as "fiduciaries," and the role of market forces allowing PBMS to contain private-sector prescription drug prices.
    O'Donnell TP; Fendler MK
    J Health Law; 2007; 40(2):205-40. PubMed ID: 17849828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Skilled nursing facilities--a clinical opportunity for pharmacists.
    Kidder SW
    Am J Hosp Pharm; 1977 Jul; 34(7):751-3. PubMed ID: 888838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of the relationships of drug dosage form, therapeutic class and pharmaceutical services with the gross margins on prescription drugs.
    Gagnon JP; Rodowskas CA
    Med Care; 1974 Jan; 12(1):49-61. PubMed ID: 4811402
    [No Abstract]   [Full Text] [Related]  

  • 40. The capitation system for pharmaceutical services.
    Provost GP
    Am J Hosp Pharm; 1973 Jun; 30(6):493. PubMed ID: 4709927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.